Managing Cardiomyopathies in Lysosomal Disorders
This CME/CE activity describes the pathophysiologies and management options for lysosomal disease patients with cardiomyopathies.
At the end of this activity, participants should be able to:
- Describe the role of the cardiologist in the team approach to care
- Describe best practices to monitor cardiac symptoms in lysosomal disorders
- Describe best practices to treat cardiac symptoms in lysosomal disorders |
|
|
The Pharmacist’s Role in Managing Patients with Worsening Heart Failure
Pharmacists play a vital role in the management of patients with heart failure (HF). Navigate through this interactive self-directed, pharmacist-targeted activity designed to optimize your decision-making to apply the most recent clinical trial data and guidance seen in real-world HF practice, particularly in patients with worsening HF and after recent HF hospitalization. Expert perspectives and insights cover guideline-directed medical therapy (GDMT) implementation and additional adjustment t... |
|
Pathways for Optimal Sequencing, Rapid Initiation, and Titration of Therapy in Patients with Heart Failure
Many patients with heart failure (HF) do not receive foundational treatment although these therapies reduce morbidity and mortality risks. The initiation and optimization of guideline-directed medical therapies (GDMT) can be challenging, but clinical practice guidelines and algorithms are available to assist.
Navigate through this interactive self-directed CME activity to apply the most recent clinical trial data and guidance to patient-specific factors seen in real-world practice. Expert p... |
|
Multidisciplinary Strategies to Prevent Hospitalization in Patients with Worsening Heart Failure
Despite guideline-directed medical therapy, many patients with heart failure (HF) with reduced ejection fraction continue to experience worsening HF and hospitalizations. As such, it is incumbent upon clinicians to improve familiarity and competence with available therapies and clinical trial data that may guide patient selection to individualize and optimize therapy for patients with HF. In this interactive infographic, clinicians can access real-world strategies and expert insights to improv... |
|
Cleveland Clinic 21st Intensive Review of Cardiology
Cleveland Clinic’s acclaimed faculty shares its unparalleled expertise with its 21st Intensive Review of Cardiology. This Board and re-certification resource serves as a forum to critically review current thinking and management of all major cardiovascular disciplines. Focus is placed on the delivery of contemporary medicine, including complex patient management and decision-making for practicing cardiologists. Worth up to 15.75 AMA PRA Category I Credits™, this enduring material is also... |
|
Irregular Care: Racial Inequities in the Management of Cardiac Rhythm Disorders
Structural racism and classism leads to many of the social determinants of health (SDoH) that cause disparities in cardiovascular (CVD) care, such as unequal preventative care, heart arrythmia treatment, and research inclusion. Interpersonal racism, including unconscious bias, worsens disproportionate CVD care, and is also a stand-alone factor for this health inequity. Underrepresented minority (URM) patients – particularly Black/African American individuals – are less likely to receive, b... |
|
Cleveland Clinic Interprofessional Approach to Liver Disease (Online Streaming & USB Formats)
The management of critically ill patients with liver disease requires the expertise of a variety of healthcare providers from multiple disciplines. Cleveland Clinic addresses their multifaceted educational needs with the Interprofessional Approach to Liver Disease. Physicians, nurses and physician assistants will benefit from the latest strategies and evidence based management guidance from an expert faculty. Worth 14 AMA PRA Category I Credits™, with ANCC and AAPA accreditation provided a... |
|
Monitor Patients with Carpal Tunnel Syndrome and Catch Transthyretin Cardiomyopathy Early in the Course
Target Audience
Healthcare providers in internal medicine, family medicine, surgery, cardiology, neurology, and healthcare professionals caring for patients with carpal tunnel syndrome and/or heart failure.
Program Overview
ATTR is a type of amyloidosis that affects the heart as well as other tissues such as the synovium of carpal tunnel. Bilateral carpal tunnel syndrome proceeds the symptoms of ATTR cardiomyopathy by a number of years. Topics on when to refer patients with carpal tunnel ... |
|
The Critical Role of Managed Care Pharmacists in Optimizing Treatment of Iron Deficiency in Patients with Heart Failure
Despite evidence-based interventions to prevent or manage heart failure (HF), poor HF-related outcomes persist as evidenced by the number of preventable HF-related hospitalizations and high readmission rates. Moreover, the economic burden that HF places on the health care system is significant. Pharmacists can improve adherence to guideline recommendations for the use of intravenous (IV) iron therapy for patients with HF and iron deficiency (ID) and develop treatment pathways and implement for... |
|
Clinical Questions in Cardiology: Using Glucagon-like Peptite-1 Receptor Agonists
The glucagon-like peptide-1 receptor agonist (GLP-1RA) class of medications has become an important option for treating patients with type 2 diabetes mellitus (T2D). Cardiovascular outcome trials also show that selected GLP-1RAs exert beneficial cardiovascular benefits in patients with and without T2D. In this activity, case studies commonly encountered in cardiology practice are utilized to prompt reflection on opportunities for reducing cardiovascular risk. Drawing on seminal research and th... |
|
Overcoming Challenges to Recognizing, Diagnosing, and Managing Transthyretin Amyloid Cardiomyopathy
Transthyretin amyloid cardiomyopathy (ATTR-CM), once considered rare, is more prevalent than previously thought. Diagnosing this condition can be a challenge, as early symptoms may be nonspecific and attributable to aging, whereas later more severe symptoms can be mistaken for other cardiovascular conditions such as heart failure or may be confused with other causes of amyloidosis. This can be particularly problematic, as it can delay appropriate treatment.
Advances in noninvasive methods f... |
|
Cleveland Clinic 25th Valve Disease, Structural Interventions & Diastology Summit (Online & USB Flash Drive)
Cleveland Clinic celebrates its silver anniversary with the 25th Valve Disease, Structural Interventions and Diastology Summit. This activity provides a comprehensive educational experience for all who diagnose and treat valve disease. A renowned faculty focuses on the mitral, aortic and tricuspid valves, with newest techniques and strategies for imaging and intervention. Worth up to 15 AMA PRA Category I Credits™, this enduring material meets Echo Lab CME requirements. Additionally, phys... |